Literature DB >> 20599197

Association of C-reactive protein and homocysteine with subclinical coronary plaque subtype and stenosis using low-dose MDCT coronary angiography.

Tsann Lin1, Juhn-Cherng Liu, Li-Ya Chang, Chien-Wei Shen.   

Abstract

OBJECTIVES: Given the uncertainty regarding the relationship of C-reactive protein (CRP) and homocysteine (Hcy) to atherosclerotic burden, our aim was to determine whether CRP and Hcy are related to the presence of subclinical coronary plaque and stenosis.
METHODS: We did a cross-sectional analysis of data gathered on 1248 consecutive, newly self-referred, middle-aged subjects who underwent health check ups at China Medical University Hospital. Participants had at least one cardiac risk factor, but no known coronary heart disease. Low-dose multidetector computed tomography coronary angiography (MDCT-CA) was used to measure coronary artery stenosis and identify plaque subtypes.
RESULTS: Subjects were divided into quartiles based on levels of high-sensitivity (hs)-CRP and Hcy. hs-CRP level and Hcy level were associated with the relative proportion of plaque subtypes; Hcy level (P<0.05) but not hs-CRP level (P>0.05) was associated with prevalence of artery segment stenosis. After multivariate adjustment for traditional cardiovascular risk factors through logistic regression analysis, neither hs-CRP level nor Hcy level was independently associated with coronary plaque subtypes and stenosis (P>0.05).
CONCLUSIONS: Subclinical atherosclerosis is mildly increased in subjects with higher CRP and Hcy levels, but this association is not independent of traditional cardiovascular risk factors. CRP and Hcy are poor predictors of atherosclerotic burden and coronary stenosis.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599197     DOI: 10.1016/j.atherosclerosis.2010.06.017

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

1.  Factors associated with coronary heart disease in COPD patients and controls.

Authors:  Christina D Svendsen; Karel K J Kuiper; Kristoffer Ostridge; Terje H Larsen; Rune Nielsen; Vidar Hodneland; Eli Nordeide; Per S Bakke; Tomas M Eagan
Journal:  PLoS One       Date:  2022-04-27       Impact factor: 3.752

2.  Homocysteine, interleukin-1β, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness.

Authors:  Zhenxiang Dai; Yang Jiao; Qingxian Fan; Anning Qi; Liang Xiao; Jingwei Li
Journal:  Exp Ther Med       Date:  2019-12-13       Impact factor: 2.447

3.  Clinical Evidence Supports a Protective Role for CXCL5 in Coronary Artery Disease.

Authors:  Saranya Ravi; Robert N Schuck; Eleanor Hilliard; Craig R Lee; Xuming Dai; Kaitlin Lenhart; Monte S Willis; Brian C Jensen; George A Stouffer; Cam Patterson; Jonathan C Schisler
Journal:  Am J Pathol       Date:  2017-11-16       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.